Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early diagnosis and treatment can prevent complications and permanent injuries. The techniques of nerve repair and regeneration aid to cure the disorders such Alzheimer’s disease, Parkinson disease, and other neurological disorders. Research Beam Model: Research Beam Product ID: 21030 5370 USD New
Nerve Repair and Regeneration Market by Surgery [Direct Neuropathy by Type (Epineural Repair, Perineural Repair, and Group Fascicular Repair), Nerve Grafting by Type (Autografts, Allografts, and Xenografts), Neuromodulation Surgery (External and Internal), and Stem Cell Therapy] and Product [Biomaterial by Type (Nerve Conduits, Nerve Protectors, Nerve Wraps, and Nerve Connectors) and Neuromodulation Surgery Devices by Type (External by Type (Transcutaneous Electrical Nerve Stimulation and Transcranial Magnetic Stimulation) and Internal by Type (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, and Others)]: Global Opportunity Analysis and Industry Forecast, 2017-2023

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Nerve Repair and Regeneration Market by Surgery [Direct Neuropathy by Type (Epineural Repair, Perineural Repair, and Group Fascicular Repair), Nerve Grafting by Type (Autografts, Allografts, and Xenografts), Neuromodulation Surgery (External and Internal), and Stem Cell Therapy] and Product [Biomaterial by Type (Nerve Conduits, Nerve Protectors, Nerve Wraps, and Nerve Connectors) and Neuromodulation Surgery Devices by Type (External by Type (Transcutaneous Electrical Nerve Stimulation and Transcranial Magnetic Stimulation) and Internal by Type (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, and Others)]: Global Opportunity Analysis and Industry Forecast, 2017-2023

 
 
 

Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early diagnosis and treatment can prevent complications and permanent injuries. The techniques of nerve repair and regeneration aid to cure the disorders such Alzheimer’s disease, Parkinson disease, and other neurological disorders.

The global nerve repair and regeneration market was valued at $5,927 million in 2016, and is estimated to garner $13,938  million by 2023, registering a CAGR of 13.0% from 2017 to 2023. The major factors that enhance the market growth are increase in geriatric population, rise in incidence of neurological & epidemic disorders, and launch of innovative products for nerve repair & regeneration. However, stringent regulatory requirements delay product approvals, thereby restraining the market growth.

The global nerve repair and regeneration market is segmented on the basis of surgery, product, and geography. Based on surgery, the market is classified into direct neuropathy, nerve grafting, neuromodulation surgery, and stem cell therapy. The neuromodulation surgeries segment contributed the highest share in 2016, owing to increase in patients suffering from neural disorders. Direct neuropathy is categorized into epineural repair, perineural repair, and group fascicular repair. Nerve grafting is subsegmented into autografts, allografts, and xenografts. Nerve modulation surgery is bifurcated into external and internal. By product, the market is divided into biomaterials and neuromodulation surgery devices. Neuromodulation surgery devices contributed the highest share in 2016, owing to the wide range of product offering for nerve repair. Biomaterial is classified into nerve conduits, nerve protectors, nerve wraps, and nerve connectors. Neuromodulation surgery devices is subsegmented into external and internal. External is further segmented into transcutaneous electrical nerve stimulation and transcranial magnetic stimulation. Internal is divided into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and others.

Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North American market accounted for a significant share in 2016, owing to growth in number of patients suffering from neurological disorders.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global nerve repair and regeneration market and the current trends & future estimations to elucidate the imminent investment pockets.
  • The report provides quantitative analysis of the industry from 2016 to 2023 to enable stakeholders to capitalize on the prevailing opportunities.
  • Extensive analysis of the market based on the surgeries and product elucidate the prevailing opportunities in these segments.
  • Comprehensive analysis of geographical regions is provided to determine the regional opportunities.
  • The key players operating in the market and their strategies are profiled to determine the competitive outlook of the market.

KEY MARKET SEGMENTS

By Surgery

  • Direct Neuropathy
    • Epineural Repair
    • Perineural Repair
    • Group Fascicular Repair
  • Nerve Grafting
    • Autografts
    • Allografts
    • Xenografts
  • Stem Cell Therapy
  • Neuromodulation Surgery
    • External Neuromodulation Surgery
    • Internal Neuromodulation Surgery

By Product

  • Biomaterials
    • Nerve Conduits
    • Nerve Protectors
    • Nerve Wraps
    • Nerve Connectors
  • Neuromodulation Surgery Devices
    • External Neuromodulation Surgery
      • Transcutaneous Electrical Nerve Stimulation
      • Transcranial Magnetic Stimulation
    • Internal Neuromodulation Surgery
      • Spinal Cord Stimulation
      • Deep Brain Stimulation
      • Sacral Nerve Stimulation
      • Vagus Nerve Stimulation
      • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa

KEY PLAYERS PROFILED IN THE REPORT

  • AxoGen Inc. (U.S.)
  • Baxter International (U.S.)
  • Boston Scientific Incorporation (U.S.)
  • Cyberonics Inc. (U.S.)
  • Integra Lifesciences Corporation (U.S.)
  • Medtronic plc (U.S.)
  • Orthomed S.A.S. (France)
  • Polyganics B.V. (Netherlands)
  • St. Jude Medical (U.S.)
  • Stryker Corporation (U.S.)

OTHER PLAYERS IN THE VALUE CHAIN

(These players are not profiled in the report, but can be included on request)

  • Alafair Biosciences Inc.
  • Covidien Plc.
  • GlaxoSmithKline Pharmaceuticals Ltd.
  • NeuroMetrix, Inc.
  • Synapse Biomedical, Inc.
  • Convergent Technologies
  • Autonomic Technologies

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

1.5. EXECUTIVE SUMMARY
1.6. CXO PERSPECTIVE

CHAPTER 2 MARKET OVERVIEW

2.1. MARKET DEFINITION AND SCOPE
2.2. KEY FINDINGS

2.2.1. Top investment pockets
2.2.2. Top winning stratgies

2.3. MARKET SHARE ANALYSIS,2016
2.4. PORTERS FIVE FORCES ANALYSIS
2.5. MARKET DYNAMICS

2.5.1. Drivers

2.5.1.1. Increase in geriatric population
2.5.1.2. Rise in prevalence of neurological & epidemic disorders
2.5.1.3. Launch of innovative products for nerve repair & regeneration

2.5.2. Restraints

2.5.2.1. Stringent regulatory requirements for product approvals

2.5.3. Opportunities

2.5.3.1. Increase in peripheral nerve injuries and neurological disorders
2.5.3.2. Improvement in the healthcare facilities in Asia-Pacific

CHAPTER 3 NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT

3.1. OVERVIEW
3.2. BIOMATERIAL

3.2.1. Key market trends
3.2.2. Key growth factors and opportunities
3.2.3. Market size and forecast
3.2.4. Nerve Conduits

3.2.4.1. Market size and forecast

3.2.5. Nerve Protectors

3.2.5.1. Market size and forecast

3.2.6. Nerve Wraps

3.2.6.1. Market size and forecast

3.2.7. Nerve Connectors

3.2.7.1. Market size and forecast

3.3. NEUROMODULATION SURGERY DEVICES

3.3.1. Key market trends
3.3.2. Key growth factors and opportunities
3.3.3. Market size and forecast
3.3.4. External neuromodulation devices

3.3.4.1. Market size and forecast
3.3.4.2. Transcutaneous Electrical Nerve Stimulation
3.3.4.3. Transcranial Magnetic Stimulation

3.3.5. Internal neuromodulation surgery

3.3.5.1. Market size and forecast
3.3.5.2. Spinal Cord Stimulation

3.3.5.2.1. Market size and forecast

3.3.5.3. Deep Brain Stimulation

3.3.5.3.1. Market size and forecast

3.3.5.4. Sacral Nerve Stimulation

3.3.5.4.1. Market size and forecast

3.3.5.5. Vagus Nerve Stimulation

3.3.5.5.1. Market size and forecast

3.3.5.6. Others

3.3.5.6.1. Market size and forecast

CHAPTER 4 NERVE REPAIR AND REGENERATION MARKET, BY SURGERIES

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. DIRECT NEUROPATHY

4.2.1. Market size and forecast
4.2.2. Epineural Repair

4.2.2.1. Market size and forecast

4.2.3. Perineural Repair

4.2.3.1. Market size and forecast

4.2.4. Group Fascicular Repair

4.2.4.1. Market size and forecast

4.3. NERVE GRAFTING

4.3.1. Market size and forecast
4.3.2. Autografts

4.3.2.1. Market size and forecast

4.3.3. Allografts

4.3.3.1. Market size and forecast

4.3.4. Xenografts

4.3.4.1. Market size and forecast

4.4. STEM CELL THERAPY

4.4.1. Market size and forecast

4.5. NEUROMODULATION SURGERY

4.5.1. Market size and forecast
4.5.2. External Neuromodulation Surgery

4.5.2.1. Market size and forecast

4.5.3. Internal Neuromodulation Surgery

4.5.3.1. Market size and forecast

CHAPTER 5 NERVE REPAIR AND REGENERATION MARKET, BY GEOGRAPHY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. U.S.: market size and forecast
5.2.5. Canada: market size and forecast
5.2.6. Mexico: market size and forecast

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Germany: market size and forecast
5.3.5. France market size and forecast
5.3.6. UK: market size and forecast
5.3.7. Italy: market size and forecast
5.3.8. Spain: market size and forecast
5.3.9. Rest of Europe: market size and forecast

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.4. Japan: market size and forecast
5.4.5. China market size and forecast
5.4.6. India: market size and forecast
5.4.7. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.4. Latin America: market size and forecast
5.5.5. Middle East market size and forecast
5.5.6. Africa: market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1. AXOGEN INC.

6.1.1. Overview
6.1.2. Operating business segments
6.1.3. Business performance

6.2. BAXTER INTERNATIONAL

6.2.1. Overview
6.2.2. Operating business segments
6.2.3. Business performance
6.2.4. Key strategic moves & developments

6.3. BOSTON SCIENTIFIC INCORPORATION

6.3.1. OVERVIEW
6.3.2. Operating business segments
6.3.3. Business performance
6.3.4. Key strategic moves & developments

6.4. CYBERONICS INC.

6.4.1. Overview
6.4.2. Operating business segments
6.4.3. Business performance
6.4.4. Key strategic moves & developments

6.5. INTEGRA LIFESCIENCES CORPORATION

6.5.1. Overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves & developments

6.6. MEDTRONIC PLC

6.6.1. Overview
6.6.2. Operating business segments
6.6.3. Business performance

6.7. ORTHOMED S.A.S.

6.7.1. Overview
6.7.2. Operating business segments
6.7.3. Business performance

6.8. POLYGANICS B.V.

6.8.1. OVERVIEW
6.8.2. Operating business segments
6.8.3. Business performance

6.9. ST. JUDE MEDICAL

6.9.1. Overview
6.9.2. Operating business segments
6.9.3. Business performance
6.9.4. Key strategic moves & developments

6.10. STRYKER CORPORATION

6.10.1. Overview
6.10.2. Operating business segments
6.10.3. Business performance

LIST OF TABLES

TABLE 1. GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2016-2023, ($ MILLION)
TABLE 2. GLOBAL NERVE REPAIR AND REGENERATION MARKET FOR BIOMATERIAL, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 3. GLOBAL NERVE REPAIR AND REGERATION MARKET, BY PRODUCT TYPE, 2016-2023, ($ MILLION)
TABLE 4. GLOBAL NERVE CONDUITS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 5. GLOBAL NERVE PROTECTORS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 6. GLOBAL NERVE WRAPS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 7. GLOBAL NERVE CONNECTORS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 8. GLOBAL NERVE REAPIR AND REGENERATION MARKET FOR NEUROMODULATION SURGERY DEVICES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 9. GLOBAL NERVE REAPIR AND REGENERATION MARKET FOR EXTERNAL NEUROMODULATION SURGERY DEVICES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 10. GLOBAL NERVE REAPIR AND REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 11. GLOBAL NERVE REAPIR AND REGENERATION MARKET FOR TRANSCARNIAL MAGNETIC STIMULATION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 12. GLOBAL NERVE REAPIR AND REGENERATION MARKET FOR INTERNAL NEUROMODULTAION SURGERY, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 13. GLOBAL NERVE REAPIR AND REGENERATION MARKET FOR INTERNAL NEUROMODULTAION SURGERY, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 14. GLOBAL NERVE REAPIR AND REGENERATION MARKET FOR INTERNAL NEUROMODULTAION SURGERY, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 15. GLOBAL NERVE REAPIR AND REGENERATION MARKET FOR INTERNAL NEUROMODULTAION SURGERY, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 16. GLOBAL NERVE REAPIR AND REGENERATION MARKET FOR INTERNAL NEUROMODULTAION SURGERY, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 17. GLOBAL NERVE REAPIR AND REGENERATION MARKET FOR INTERNAL NEUROMODULTAION SURGERY, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 18. GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY SURGERIES, 2016-2023 ($ MILLION)
TABLE 19. GLOBAL NERVE REPAIR AND REGENERATION MARKET FOR DIRECT NEUROPATHY, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 20. GLOBAL NERVE REPAIR AND REGENERATION MARKET FOR EPINEURAL REPAIR, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 21. GLOBAL NERVE REPAIR AND REGENERATION MARKET FOR PERINEURAL REPAIR, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 22. GLOBAL NERVE REPAIR AND REGENERATION MARKET FOR GROUP FASCICULAR REPAIR, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 23. GLOBAL NERVE REPAIR AND REGENERATION MARKET FOR NERVE GRAFTING, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 24. GLOBAL NERVE REPAIR AND REGENERATION MARKET FOR AUTOGRAFTS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 25. GLOBAL NERVE REPAIR AND REGENERATION MARKET FOR ALLOGRAFTS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 26. GLOBAL NERVE REPAIR AND REGENERATION MARKET FOR XENOGRAFTS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 27. GLOBAL NERVE REAPIR AND REGENERATION MARKET FOR STEM CELL THERAPY, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 28. GLOBAL NERVE REPAIR AND REGENERATION MARKET FOR NEUROMODULATION SURGERY, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 29. GLOBAL NERVE REPAIR AND REGENERATION MARKET FOR EXTERNAL NEUROMODULATION SURGERY, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 30. GLOBAL NERVE REPAIR AND REGENERATION MARKET FOR INTERNAL NEUROMODULATION SURGERY, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 31. GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 32. NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 33. NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT TYPE, 20162023 ($MILLION)
TABLE 34. NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY SURGERIES, 20162023 ($MILLION)
TABLE 35. EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 20162023 ($MILLION)
TABLE 36. EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT TYPE, 20162023 ($MILLION)
TABLE 37. EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY SURGERIES, 20162023 ($MILLION)
TABLE 38. ASIA-PACIFIC: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2016-2023($MILLION)
TABLE 39. ASIA-PACIFIC: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT TYPE, 20162023 ($MILLION)
TABLE 40. ASIA-PACIFIC: NERVE REPAIR AND REGENERATION MARKET, BY SUGERIES, 20162023 ($MILLION)
TABLE 41. LAMEA: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2016-2023($MILLION)
TABLE 42. LAMEA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT TYPE, 20162023 ($MILLION)
TABLE 43. LAMEA: NERVE REPAIR AND REGENERATION MARKET, BY SURGERIES, 20162023 ($MILLION)
TABLE 44. AXOGEN INC.: COMPANY SNAPSHOT
TABLE 45. AXOGEN INC.: BUSINESS SEGMENTS
TABLE 46. BAXTER INTERNATIONAL COMPANY SNAPSHOT
TABLE 47. BAXTER INTERNATIONAL BUSINESS SEGMENTS
TABLE 48. BOSTON SCIENTIFIC INCORPORATION: COMPANY SNAPSHOT
TABLE 49. BOSTON SCIENTIFIC INCORPORATION: BUSINESS SEGMENTS
TABLE 50. CYBERONICS INC.: COMPANY SNAPSHOT
TABLE 51. CYBERONICS INC.: BUSINESS SEGMENTS
TABLE 52. INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 53. INTEGRA LIFESCIENCES CORPORATION: BUSINESS SEGMENTS
TABLE 54. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 55. MEDTRONIC PLC: BUSINESS SEGMENTS
TABLE 56. ORTHOMED S.A.S..: COMPANY SNAPSHOT
TABLE 57. ORTHOMED S.A.S..: BUSINESS SEGMENTS
TABLE 58. POLYGANICS B.V.: COMPANY SNAPSHOT
TABLE 59. POLYGANICS B.V.: BUSINESS SEGMENTS
TABLE 60. ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 61. ST. JUDE MEDICAL: BUSINESS SEGMENTS
TABLE 62. STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 63. STRYKER CORPORATION: BUSINESS SEGMENTS

LIST OF FIGURES

FIGURE 1. NERVE REPAIR AND REGENERATION: MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS IN NERVE REPAIR AND REGENERATION MARKET
FIGURE 3. MARKET SHARE ANALYSIS: NERVE REPAIR AND REGENERATION MARKET, 2016
FIGURE 9. INCIDENCE RATE OF CHRONIC DISEASES, 19952030
FIGURE 10. U.S.: NERVE REPAIR AND REGENERATION MARKET, 2016-2023($MILLION)
FIGURE 11. CANADA: NERVE REPAIR AND REGENERATION MARKET, 2016-2023($MILLION)
FIGURE 12. MEXICO: NERVE REPAIR AND REGENERATION MARKET, 2016-2023($MILLION)
FIGURE 13. GERMANY: NERVE REPAIR AND REGENERATION MARKET, 2016-2023($MILLION)
FIGURE 14. FRANCE: NERVE REPAIR AND REGENERATION MARKET, 2016-2023($MILLION)
FIGURE 15. UK: NERVE REPAIR AND REGENERATION MARKET, 2016-2023($MILLION)
FIGURE 16. ITALY: NERVE REPAIR AND REGENERATION MARKET, 2016-2023($MILLION)
FIGURE 17. SPAIN: NERVE REPAIR AND REGENERATION MARKET, 2016-2023($MILLION)
FIGURE 18. REST OF EUROPE: NERVE REPAIR AND REGENERATION MARKET, 2016-2023($MILLION)
FIGURE 19. JAPAN: NERVE REPAIR AND REGENERATION MARKET, 2016-2023($MILLION)
FIGURE 20. CHINA: NERVE REPAIR AND REGENERATION MARKET, 2016-2023($MILLION)
FIGURE 21. INDIA: NERVE REPAIR AND REGENERATION MARKET, 2016-2023($MILLION)
FIGURE 22. REST OF ASIA-PACIFIC: NERVE REPAIR AND REGENERATION MARKET, 2016-2023($MILLION)
FIGURE 23. LATIN AMERICA: NERVE REPAIR AND REGENERATION MARKET, 2016-2023($MILLION)
FIGURE 24. MIDDLE EAST: NERVE REPAIR AND REGENERATION MARKET, 2016-2023($MILLION)
FIGURE 25. AFRICA: NERVE REPAIR AND REGENERATION MARKET, 2016-2023($MILLION)
FIGURE 26. AXOGEN INC. - TOTAL REVENUE, 20142016 ($MILLION)
FIGURE 27. AXOGEN INC. - REVENUE, BY PRODUCT CATEGORY, 2016 (%)
FIGURE 28. AXOGEN INC. - REVENUE, BY GEOGRAPHY, 2016 (%)
FIGURE 29. BAXTER INTERNATIONAL - TOTAL REVENUE, 20142016 ($MILLION)
FIGURE 30. BAXTER INTERNATIONAL - REVENUE, BY PRODUCT CATEGORY, 2016 (%)
FIGURE 31. BAXTER INTERNATIONAL - REVENUE, BY GEOGRAPHY, 2016 (%)
FIGURE 32. BOSTON SCIENTIFIC INCORPORATION - TOTAL REVENUE, 20132015 ($MILLION)
FIGURE 33. BOSTON SCIENTIFIC INCORPORATION - REVENUE, BY PRODUCT CATEGORY, 2015 (%)
FIGURE 34. BOSTON SCIENTIFIC INCORPORATION - REVENUE, BY GEOGRAPHY, 2016 (%)
FIGURE 35. CYBERONICS INC. - TOTAL REVENUE, 20132015 ($MILLION)
FIGURE 36. CYBERONICS INC. - REVENUE, BY PRODUCT CATEGORY, 2015 (%)
FIGURE 37. CYBERONICS INC. - REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 38. INTEGRA LIFESCIENCES CORPORATION -TOTAL REVENUE, 20132015 ($MILLION)
FIGURE 39. INTEGRA LIFESCIENCES CORPORATION - REVENUE, BY PRODUCT CATEGORY, 2015 (%)
FIGURE 40. INTEGRA LIFESCIENCES CORPORATION -REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 41. MEDTRONIC PLC - TOTAL REVENUE, 20132015 ($MILLION)
FIGURE 42. MEDTRONIC PLC - REVENUE, BY PRODUCT CATEGORY, 2015 (%)
FIGURE 43. MEDTRONIC PLC: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 44. ORTHOMED S.A.S. - TOTAL REVENUE, 20132015 ($MILLION)
FIGURE 45. ORTHOMED S.A.S. - REVENUE, BY PRODUCT CATEGORY, 2015 (%)
FIGURE 46. ORTHOMED S.A.S.: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 47. POLYGANICS B.V. - TOTAL REVENUE, 20132015 ($MILLION)
FIGURE 48. POLYGANICS B.V. - REVENUE, BY PRODUCT CATEGORY, 2015 (%)
FIGURE 49. POLYGANICS B.V. REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 50. ST. JUDE MEDICAL - TOTAL REVENUE, 20132015 ($MILLION)
FIGURE 51. ST. JUDE MEDICAL - REVENUE, BY PRODUCT CATEGORY, 2015 (%)
FIGURE 52. ST. JUDE MEDICAL.: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 53. STRYKER CORPORATION - TOTAL REVENUE, 20132015 ($MILLION)
FIGURE 54. STRYKER CORPORATION - REVENUE, BY PRODUCT CATEGORY, 2015 (%)
FIGURE 55. STRYKER CORPORATION -REVENUE, BY GEOGRAPHY, 2015 (%)